AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX)

About the company

AcelRx Pharmaceuticals, Inc. engages in the development and commercialization of therapies use in medically supervised settings. Its products include sufentanil, DZUVEO, DSUVIA ZALVISO US and ZALVISO EU. The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in Redwood City, CA.

Sector

Health Technology

Industry

Pharmaceuticals: Other

Employees

99

CEO

Vincent J. Angotti

Exchange

NASDAQ

Website

http://www.acelrx.com

$2.00M

Total Revenue

99

Employees

$91.20M

Market Capitalization

-1.63

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$-4M

Operating Margin (in %)

Total operating margin

$-10M

Net Margin (in %)

Total net margin

$-13M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Horizon Therapeutics Plc HZNP 11600.40 1376.00 4.95 18.29 43.06
Catalent, Inc. CTLT 10932.13 2872.00 5.49 104.81 3.63
Perrigo Co. Plc PRGO 7561.03 4837.00 1.30 51.58 3.02
Bausch Health Cos., Inc. BHC 6512.14 8597.00 9.09 -3.44 -21.96
Jazz Pharmaceuticals Plc JAZZ 6255.75 2188.00 2.16 22.86 12.81
United Therapeutics Corp. UTHR 5188.38 1443.00 1.80 10.01 36.59
MyoKardia, Inc. MYOK 4329.06 34.00 12.58 -13.96 -201.73
Axsome Therapeutics, Inc. AXSM 2672.60 None 18.14 -29.71 None
ArQule, Inc. ARQL 2240.00 5.00 15.75 -55.56 -808.06
Pacira Biosciences, Inc. PCRX 2199.54 435.00 5.90 -5237.00 -0.02
SAGE Therapeutics, Inc. SAGE 2162.16 9.00 2.54 -3.34 -413.06
Corcept Therapeutics, Inc. CORT 2095.96 335.00 4.81 19.75 31.64
Prestige Consumer Healthcare, Inc. PBH 1844.67 963.00 1.55 13.01 14.77
Revolution Medicines, Inc. RVMD 1829.59 48.00 4.75 -25.84 -146.29
Madrigal Pharmaceuticals, Inc. MDGL 1673.70 0.00 4.47 -16.38 -624.74
Ironwood Pharmaceuticals, Inc. IRWD 1601.40 440.00 -22.67 18.89 19.14
Innoviva, Inc. INVA 1580.87 285.00 3.74 8.18 66.41
Intercept Pharmaceuticals, Inc. ICPT 1506.88 272.00 -44.85 -4.39 -127.53
Portola Pharmaceuticals, Inc. PTLA 1329.78 121.00 19.53 -4.77 -232.73
Zogenix, Inc. ZGNX 1313.55 5.00 3.59 -3.09 -241.62
Supernus Pharmaceuticals, Inc. SUPN 1254.96 402.00 1.99 10.76 28.90
Theravance Biopharma, Inc. TBPH 1196.43 88.00 -8.40 -4.85 -280.80
Revance Therapeutics, Inc. RVNC 1181.11 0.00 4.66 -6.33 41.82
Amphastar Pharmaceuticals, Inc. AMPH 1088.78 327.00 2.72 21.37 15.90
Endo International Plc ENDP 795.72 3014.00 -1.09 -2.84 -9.09
BellRing Brands, Inc. BRBR 766.74 954.00 -0.42 5.82 13.98
Eagle Pharmaceuticals, Inc. EGRX 684.60 192.00 3.68 271.67 1.29
Aerie Pharmaceuticals, Inc. AERI 678.96 79.00 5.39 -3.35 -252.92
Assembly Biosciences, Inc. ASMB 672.22 16.00 3.01 -6.76 -601.75
Collegium Pharmaceutical, Inc. COLL 593.64 299.00 4.25 -45.95 -4.21
Anika Therapeutics, Inc. ANIK 537.18 125.00 1.86 19.38 22.73
Catalyst Pharmaceuticals, Inc. CPRX 514.67 119.00 5.01 11.73 36.09
Intersect ENT, Inc. XENT 411.20 102.00 3.88 -8.24 -48.61
BioDelivery Sciences International, Inc. BDSI 408.48 130.00 5.84 -55.50 -5.01
ANI Pharmaceuticals, Inc. ANIP 370.68 203.00 1.90 -237.62 -0.67
Albireo Pharma, Inc. ALBO 337.35 11.00 3.43 -4.41 -730.55
MEI Pharma, Inc. MEIP 289.67 5.00 4.99 -7.43 -539.48
Mallinckrodt Plc MNK 204.12 3037.00 0.11 -0.17 -39.56
Marinus Pharmaceuticals, Inc. MRNS 168.21 0.00 6.51 -2.50 None
Agile Therapeutics, Inc. AGRX 166.97 None 2.72 -8.09 None
Zynerba Pharmaceuticals, Inc. ZYNE 144.90 0.00 2.38 -4.04 -699.94
Cerecor, Inc. CERC 117.76 7.00 7.53 -5.22 -429.22
Ampio Pharmaceuticals, Inc. AMPE 94.38 1.00 66.00 -5.08 None
AcelRx Pharmaceuticals, Inc. ACRX 91.20 2.00 -1.68 -1.63 -644.25
Evoke Pharma, Inc. EVOK 84.96 None 29.50 -12.64 None
Adamas Pharmaceuticals, Inc. ADMS 71.68 57.00 -4.57 -0.77 -160.44
CTI BioPharma Corp. CTIC 69.62 3.00 3.11 -1.69 -111.83
Aclaris Therapeutics, Inc. ACRS 67.65 4.00 1.19 -0.49 None
Oramed Pharmaceuticals, Inc. ORMP 63.36 3.00 5.10 -4.96 -464.15
Cassava Sciences, Inc. SAVA 54.34 41.00 2.86 -11.92 76.71
SCYNEXIS, Inc. SCYX 48.89 0.00 10.27 -1.26 -30.84
Cumberland Pharmaceuticals, Inc. CPIX 48.60 47.00 0.99 -10.80 -9.59
Natural Alternatives International, Inc. NAII 48.37 114.00 0.66 -12.80 -3.19
IsoRay, Inc. ISR 37.52 9.00 7.00 -11.20 -36.08
Lipocine, Inc. LPCN 36.90 0.00 8.79 -2.46 None
Acasti Pharma, Inc. ACST 35.84 827.00 2.33 -0.58 -7.45
Neos Therapeutics, Inc. NEOS 34.50 65.00 -2.65 -1.97 -26.74
PLx Pharma, Inc. PLXP 27.99 0.00 -2.68 -2.96 119.04
CytRx Corp. CYTR 22.11 0.00 1.60 -3.19 408.46
EyeGate Pharmaceuticals, Inc. EYEG 19.00 3.00 2.36 -1.60 -264.21
Regulus Therapeutics, Inc. RGLS 14.49 0.00 1.28 -0.68 -272.13
Tetraphase Pharmaceuticals, Inc. TTPH 12.30 8.00 0.65 -0.15 -798.18
Intec Pharma Ltd. NTEC 10.90 None 1.40 -0.25 None
VIVUS, Inc. VVUS 8.69 73.00 -0.19 -0.29 -39.28
Sonoma Pharmaceuticals, Inc. SNOA 6.74 19.00 1.07 -2.16 -25.58
KemPharm, Inc. KMPH 6.02 15.00 -0.17 -0.35 -120.48
Hepion Pharmaceuticals, Inc. HEPA 5.68 None 1.77 -0.48 None
Tonix Pharmaceuticals Holding Corp. TNXP 4.20 None 1.05 -0.09 None
Ritter Pharmaceuticals, Inc. RTTR 0.45 None 0.17 -0.03 None

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Asure Software Inc (ASUR): Hedge Funds In Wait-and-See Mode

7d ago, source: YAHOO!

The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold ...

La Jolla Pharmaceutical Rekindles Interest In Tetraphase With Sweetened Offer

11d ago, source: Benzinga.com on MSN.com

The bidding war for Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH) seems to be far from over. What Happened: Tetraphase ...

ACRX AcelRx Pharmaceuticals, Inc. Common Stock

7d ago, source: Nasdaq

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...

Merger Arbitrage Mondays - Tetraphase Pharmaceuticals Finds A New Home

4d ago, source: Seeking Alpha

Merger activity decreased last week with one new deal announced. Tetraphase Pharmaceuticals agreed to be acquired by La Jolla Pharmaceutical Company. Waste Mana ...

Trade Alert: The Independent Chairman Of AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), Adrian Adams, Has Just Spent US$129k Buying 133% More Shares

16d ago, source: YAHOO!

Investors who take an interest in AcelRx Pharmaceuticals, Inc. ( NASDAQ:ACRX) should definitely note that the Independent ...

La Jolla Pharma makes unsolicited bid for Tetraphase Pharma

11d ago, source: Seeking Alpha

The bidding competition for Tetraphase Pharmaceuticals (NASDAQ:TTPH) is not over yet. La Jolla Pharmaceutical (NASDAQ:LJPC) has submitted an unsolicited bid of $43.0M in cash plus an additional $16.0 ...

AcelRx Pharmaceuticals Announces It Will Not Further Revise Its Offer to Acquire Tetraphase

29d ago, source: PR Newswire

REDWOOD CITY, Calif., June 3, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (AcelRx) (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.